Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer
Scientific Lecture | Kevin Harrington | FRONTAL
Finder | HCA UK
Professor Kevin Harrington | The Royal Marsden
Potential of immunotherapy in head and neck cancer | VJOncology
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
Prof. Kevin Harrington | HSTalks
Scientific Advisory Board – PsiVac
Longtime Fan Uses Ducks Hockey in His Cancer Fight
Professor Kevin Harrington, I [IMAGE] | EurekAlert! Science News Releases
Kevin Harrington, PhD on KEYNOTE-048 #ASCO2020 #ASCO
Professor Kevin Harrington - YouTube
Potential of immunotherapy in head and neck cancer | VJOncology
Loop | Kevin Joseph Harrington
Clinical results, patient cases and future developments II: Head & neck cancer – Kevin Harrington on Vimeo
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
The value of PD-L1 as a biomarker beyond lung cancers - YouTube
